In analogy with breast cancer and other malignancies, enrichment in ERRB2 amplification/HER2 overexpression (HER2 + ) has been recently described in a cohort of patients with BM from gastrointestinal tumours [3]. The gene discussed is ERBB2; the disease is breast carcinoma.